💨 Abstract
The McKinsey & Company report, presented at the 10th Global Pharmaceutical Quality Summit, shows a 50% reduction in US FDA 'official action indicated' (OAI) over the last decade for Indian-made drugs.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Raksha Rajya Mantri meets Commissioner for Defence & Space, European Commission
NABARD sees Rs 2.8 lakh crore priority sector lending potential in Punjab
Leopard kills woman collecting fodder in UP's Bijnor forest
Fire-related deaths in Delhi drop 74% so far this year, shows official data
Centre extends deadline for Mahadayi water disputes tribunal report submission
Worried over lack of people's representation, hope municipal polls happen earliest: Fadnavis
India, EU discuss ways to bolster collaboration on climate change, circular economy
Centre, states to ensure future generation gets the best of education: Rajnath Singh
Soccer-Manager Nielsen proud of Japan after SheBelieves win over US
Ranji Trophy final: Sachin's fighting 82 takes Kerala to 298/6 against Vidarbha
Powered by MessengerX.io